% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sonquiqua sonquiqua Jan 2, 2013 1:07 PM Flag

    110 phase 2 trials

    Thanks for looking into it.... you views are very appreciated. GERN states they will go after all hematological conditions, they say that for most of those telomeres are short... Chip Scarlett has a good record of success, this is a plus for the company.

105.51Apr 20 4:00 PMEDT